GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dc Healthcare Holdings Bhd (XKLS:0283) » Definitions » Research & Development

Dc Healthcare Holdings Bhd (XKLS:0283) Research & Development : RM0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Dc Healthcare Holdings Bhd Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Dc Healthcare Holdings Bhd's Research & Development for the six months ended in Dec. 2023 was RM0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was RM0.00 Mil.

Dc Healthcare Holdings Bhd Research & Development Historical Data

The historical data trend for Dc Healthcare Holdings Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dc Healthcare Holdings Bhd Research & Development Chart

Dc Healthcare Holdings Bhd Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- - - - -

Dc Healthcare Holdings Bhd Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development - - - - -

Dc Healthcare Holdings Bhd Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was RM0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dc Healthcare Holdings Bhd  (XKLS:0283) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dc Healthcare Holdings Bhd Research & Development Related Terms

Thank you for viewing the detailed overview of Dc Healthcare Holdings Bhd's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Dc Healthcare Holdings Bhd (XKLS:0283) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dc Healthcare Holdings Bhd (XKLS:0283) » Definitions » Research & Development
Comparable Companies
XKLS:0222 XKLS:03023 XKLS:0101 HCA SAU:4013 SZSE:300015 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE NSE:APOLLOHOSP ASX:RHC DVA AGL ACHC BOM:543220
Traded in Other Exchanges
N/A
Address
Centrepoint South Mid Valley City, Suites 22.01, 22.02 & 22.05, Level 22, Lingkaran Syed Putra, Kuala Lumpur, MYS, 59200
Website
https://www.dchealthcareholdings.com
Dc Healthcare Holdings Bhd Is an investment holding company. Through its subsidiaries, the company provides Aesthetic Services specializing in Non-Invasive and Minimally-Invasive procedures. Non-Invasive procedures are medical procedures that do not involve entering the body through surgical incisions; whilst Minimally Invasive procedures limit the size and quantity of incisions and injections thereby reducing wound healing time, associated pain and risk of infection. The business activities are categorized into 2 segments, Aesthetic Services, and General Medical Services. The majority of revenue is derived from the Aesthetic Services segment.

Dc Healthcare Holdings Bhd (XKLS:0283) Headlines

No Headlines